Cargando…

Chronic recurrent multifocal osteomyelitis (CRMO) – advancing the diagnosis

BACKGROUND: Chronic recurrent multifocal osteomyelitis (CRMO) is a little known inflammatory bone disease occurring primarily in children and adolescents. Delays in referral and diagnosis may lead to prolonged courses of antibiotics with in-patient care, unnecessary radiation exposure from multiple...

Descripción completa

Detalles Bibliográficos
Autores principales: Roderick, M. R., Shah, R., Rogers, V., Finn, A., Ramanan, A. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006369/
https://www.ncbi.nlm.nih.gov/pubmed/27576444
http://dx.doi.org/10.1186/s12969-016-0109-1
_version_ 1782451050508189696
author Roderick, M. R.
Shah, R.
Rogers, V.
Finn, A.
Ramanan, A. V.
author_facet Roderick, M. R.
Shah, R.
Rogers, V.
Finn, A.
Ramanan, A. V.
author_sort Roderick, M. R.
collection PubMed
description BACKGROUND: Chronic recurrent multifocal osteomyelitis (CRMO) is a little known inflammatory bone disease occurring primarily in children and adolescents. Delays in referral and diagnosis may lead to prolonged courses of antibiotics with in-patient care, unnecessary radiation exposure from multiple plain radiographs or bone scans and repeated surgery including bone biopsies. Children (aged < 18 years) diagnosed with CRMO between January 2005 and December 2012, reviewed at Bristol Royal Hospital for Children were included and all available data collected. Information regarding CRMO was sent to all orthopaedic surgeons in the region in 2009. The aim of the study was to examine the features of the cohort, to examine the length of time to diagnosis and to explore the criteria used for diagnosis with and without biopsy. FINDINGS: Over an 8 year period, 41 patients were diagnosed with CRMO. Symptom onset occurred at a median of 9 years of age and time to diagnosis had a median of 15 months (range 0–92). Correlation coefficient analysis for time to diagnosis by year showed statistical significance with a decreasing trend. From the cohort data, diagnostic criteria were developed; applied retrospectively, 34 (83 %) children may have been diagnosed using the criteria, without a biopsy. CONCLUSIONS: The data suggest that increasing knowledge of this condition may shorten time to diagnosis. Use of the Bristol diagnostic criteria by an experienced clinician may obviate the need for biopsy in some patients.
format Online
Article
Text
id pubmed-5006369
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50063692016-09-01 Chronic recurrent multifocal osteomyelitis (CRMO) – advancing the diagnosis Roderick, M. R. Shah, R. Rogers, V. Finn, A. Ramanan, A. V. Pediatr Rheumatol Online J Short Report BACKGROUND: Chronic recurrent multifocal osteomyelitis (CRMO) is a little known inflammatory bone disease occurring primarily in children and adolescents. Delays in referral and diagnosis may lead to prolonged courses of antibiotics with in-patient care, unnecessary radiation exposure from multiple plain radiographs or bone scans and repeated surgery including bone biopsies. Children (aged < 18 years) diagnosed with CRMO between January 2005 and December 2012, reviewed at Bristol Royal Hospital for Children were included and all available data collected. Information regarding CRMO was sent to all orthopaedic surgeons in the region in 2009. The aim of the study was to examine the features of the cohort, to examine the length of time to diagnosis and to explore the criteria used for diagnosis with and without biopsy. FINDINGS: Over an 8 year period, 41 patients were diagnosed with CRMO. Symptom onset occurred at a median of 9 years of age and time to diagnosis had a median of 15 months (range 0–92). Correlation coefficient analysis for time to diagnosis by year showed statistical significance with a decreasing trend. From the cohort data, diagnostic criteria were developed; applied retrospectively, 34 (83 %) children may have been diagnosed using the criteria, without a biopsy. CONCLUSIONS: The data suggest that increasing knowledge of this condition may shorten time to diagnosis. Use of the Bristol diagnostic criteria by an experienced clinician may obviate the need for biopsy in some patients. BioMed Central 2016-08-30 /pmc/articles/PMC5006369/ /pubmed/27576444 http://dx.doi.org/10.1186/s12969-016-0109-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Roderick, M. R.
Shah, R.
Rogers, V.
Finn, A.
Ramanan, A. V.
Chronic recurrent multifocal osteomyelitis (CRMO) – advancing the diagnosis
title Chronic recurrent multifocal osteomyelitis (CRMO) – advancing the diagnosis
title_full Chronic recurrent multifocal osteomyelitis (CRMO) – advancing the diagnosis
title_fullStr Chronic recurrent multifocal osteomyelitis (CRMO) – advancing the diagnosis
title_full_unstemmed Chronic recurrent multifocal osteomyelitis (CRMO) – advancing the diagnosis
title_short Chronic recurrent multifocal osteomyelitis (CRMO) – advancing the diagnosis
title_sort chronic recurrent multifocal osteomyelitis (crmo) – advancing the diagnosis
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006369/
https://www.ncbi.nlm.nih.gov/pubmed/27576444
http://dx.doi.org/10.1186/s12969-016-0109-1
work_keys_str_mv AT roderickmr chronicrecurrentmultifocalosteomyelitiscrmoadvancingthediagnosis
AT shahr chronicrecurrentmultifocalosteomyelitiscrmoadvancingthediagnosis
AT rogersv chronicrecurrentmultifocalosteomyelitiscrmoadvancingthediagnosis
AT finna chronicrecurrentmultifocalosteomyelitiscrmoadvancingthediagnosis
AT ramananav chronicrecurrentmultifocalosteomyelitiscrmoadvancingthediagnosis